亿康先达
Search
Select region
Close filter
Featured Insight

Tapping R&D Talent Pools in Senior Academia

Tapping R&D talent pools in senior academia

Faced with a shrinking pool of top R&D talent, a growing number of companies in the sector are recruiting academics and top researchers for senior management roles.

But many of these appointments are unsuccessful, with failure rates as high as 75%, because candidates from academic backgrounds lack the managerial skills required to complement their scientific expertise. To boost the success of such appointments, companies need to understand and clearly identify the leadership competences required by academic candidates seeking to switch to a commercial role. But what are these key competences?

Based on the results of over 25,000 leader and executive assessments in recent years, Egon Zehnder has developed a leadership model built on the following 5 core competencies:

  • The ability to collaborate and influence: instead of issuing commands and operating in isolation, like many lab chiefs, senior R&D leaders need to be capable of cooperating with colleagues in different functional areas and influencing those outside their direct line of command.
  • Team leadership calls for strong consensus-building and alignment skills as R&D leaders must often head highly matrixed, cross-functional project teams. Looking to the future, R&D leaders should also be able to develop the leadership talent pipeline.
  • Commercial orientation is a key attribute that many academics lack. Their funding track record, however, is often a good indicator of a candidate’s business sense, as is any industry consulting experience.
  • Results orientation: while even failed experiments can be considered interesting in science, pharma companies want results. Potential R&D leaders must consequently demonstrate an ability to find creative short-term solutions to setbacks and to achieve goals on schedule.
  • Strategic orientation: unlike researchers, companies do not share their R&D expertise. On the contrary, research programs are secret and conceived with a maximum commercial yield in mind. R&D leaders must be in a position to understand this dynamic and assess the broader impact of individual research projects on a company’s overall product portfolio.

After finding suitable candidates in academia, companies must then persuade them to make the move to industry: And that is not always easy. Greater job instability, the fear of isolation from the academic world and misgivings about their business skills are all obstacles to accepting an industry job that companies need to overcome. Firms should also ensure that new recruitees are supported by a comprehensive onboarding process tailored to address any possible gaps in candidates’ commercial knowledge.

Although recruiting senior academics may seem like a complex process, the results can be impressive. Moreover, as conditions in the global pharma industry toughen up, innovation will become an increasingly important source of competitive advantage.

Investing in recruiting senior R&D talent from the academic sector should therefore be seen by pharma companies as a major step towards future success.

Please note: This is a summary of an editorial entitled: “Going to the dark side: success factors for companies leveraging senior academic talent,” by Joanne W. Yun published in Drug Discovery Today

本文相关主题

Related content

上下一心、共克新冠:亚洲供应链高管分享心得

上下一心、共克新冠:亚洲供应链高管分享心得

供应链与运营

Egon Zehnder interviewed a dozen supply chain leaders and executives in Asia in recent days to see what they’ve learned about managing the crisis. 阅读更多

上下一心、共克新冠

上下一心、共克新冠

领导力解决方案

企业领袖分享历次危机应对心得与对当下的启示 阅读更多

2018 Global Board Diversity Tracker: Who's Really On Board?

2018 Global Board Diversity Tracker: Who's Really On Board?

董事会咨询服务

Egon Zehnder tracked gender and international diversity on boards around the world for the past 14 years. Where do 44 countries stack up? 阅读更多

Changing language

Close icon

You are switching to an alternate language version of the Egon Zehnder website. The page you are currently on does not have a translated version. If you continue, you will be taken to the alternate language home page.

Continue to the website

Back to top